IL17A and hepatocellular carcinoma: In the KEGG analysis results, cell cycle (hsa04110), small cell lung cancer (hsa05222), IL-17 signaling pathway (hsa04657), hepatocellular carcinoma (hsa05225), bladder cancer (hsa05219), and microRNAs in cancer (hsa05206) were the most enriched pathways (Figure 7D).